Cargando…

Prevalence, severity, duration and resolution of cholestasis after acute liver failure

OBJECTIVE: Persistent cholestasis may follow acute liver failure (ALF), but its course remains unknown. We aimed to describe the prevalence, onset, severity, duration and resolution of post-ALF cholestasis. DESIGN: Cohort of 127 adult patients with ALF at a liver transplantation centre identified us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warming, Scott, Michel, Claire, Serpa Neto, Ary, Kishore, Kartik, Marhoon, Nada, Holmes, Natasha, Bellomo, Rinaldo, Testro, Adam, Sinclair, Marie, Gow, Paul, Warrillow, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045116/ https://www.ncbi.nlm.nih.gov/pubmed/35473828 http://dx.doi.org/10.1136/bmjgast-2021-000801

Ejemplares similares

Natural language processing diagnosed behavioral disturbance vs confusion assessment method for the intensive care unit: prevalence, patient characteristics, overlap, and association with treatment and outcome
por: Young, Marcus, et al.
Publicado: (2022)

Decompensated metabolic acidosis in the emergency department: Epidemiology, sodium bicarbonate therapy, and clinical outcomes
por: Guy, Christopher, et al.
Publicado: (2023)

Natural language processing to assess the epidemiology of delirium-suggestive behavioural disturbances in critically ill patients
por: Young, Marcus, et al.
Publicado: (2023)

Natural language processing diagnosed behavioural disturbance phenotypes in the intensive care unit: characteristics, prevalence, trajectory, treatment, and outcomes
por: Young, Marcus, et al.
Publicado: (2023)

Cholestasis Due to USP53 Deficiency
por: Bull, Laura N., et al.
Publicado: (2021)

Aggressive nutrition in extremely low birth weight infants: impact on parenteral nutrition associated cholestasis and growth
por: Repa, Andreas, et al.
Publicado: (2016)

MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure
por: Triantafyllou, Evangelos, et al.
Publicado: (2018)

Presentation and Outcomes of Infants With Idiopathic Cholestasis: A Multicenter Prospective Study
por: Hertel, Paula M., et al.
Publicado: (2021)

Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials
por: Ben-Horin, Shomron, et al.
Publicado: (2019)

Epidemiology and outcomes of acute liver failure in Australia
por: Hey, Penelope, et al.
Publicado: (2019)

TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
por: Martin, Perrine, et al.
Publicado: (2015)

Prolonged dual hypothermic oxygenated machine preservation (DHOPE-PRO) in liver transplantation: study protocol for a stage 2, prospective, dual-arm, safety and feasibility clinical trial
por: Brüggenwirth, Isabel M A, et al.
Publicado: (2022)

Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials
por: Naorungroj, Thummaporn, et al.
Publicado: (2022)

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
por: Xiao, Fei, et al.
Publicado: (2015)

Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
por: Conche, Claire, et al.
Publicado: (2023)

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
por: Montagner, Alexandra, et al.
Publicado: (2016)

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis
por: Van Renne, Nicolaas, et al.
Publicado: (2018)

TGF-β2 silencing to target biliary-derived liver diseases
por: Dropmann, Anne, et al.
Publicado: (2020)

Reply: COVID-19 Is Not Comparable to H1N1 Influenza
por: Udy, Andrew A., et al.
Publicado: (2022)

Sodium bicarbonate therapy for metabolic acidosis in critically ill patients: a survey of Australian and New Zealand intensive care clinicians
por: Neto, Ary Serpa, et al.
Publicado: (2023)

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020)

Sodium bicarbonate in 5% dextrose: can clinicians tell the difference?
por: Jude, Briony, et al.
Publicado: (2023)

Stability of bicarbonate in normal saline: a technical report
por: Naorungroj, Thummaporn, et al.
Publicado: (2023)

Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects
por: Kechagias, S, et al.
Publicado: (2008)

Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection
por: Deuffic-Burban, S, et al.
Publicado: (2008)

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
por: Zhang, H W, et al.
Publicado: (2008)

Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection
por: Fitzmaurice, Karen, et al.
Publicado: (2011)

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
por: Hallsworth, Kate, et al.
Publicado: (2011)

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes
por: Mengshol, J A, et al.
Publicado: (2009)

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
por: Chew, Valerie, et al.
Publicado: (2011)

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
por: Thomson, Emma C, et al.
Publicado: (2010)

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
por: Ahlén, G, et al.
Publicado: (2009)

The paradox of NKp46(+) natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment
por: Pembroke, Tom, et al.
Publicado: (2014)

Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes
por: Manousou, Pinelopi, et al.
Publicado: (2014)

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
por: Colombo, M, et al.
Publicado: (2014)

Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene
por: Watanabe, Tsunamasa, et al.
Publicado: (2013)

Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
por: Govaere, Olivier, et al.
Publicado: (2014)

A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
por: Chan, Tim Hon Man, et al.
Publicado: (2014)

Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
por: Amaddeo, Giuliana, et al.
Publicado: (2015)

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection
por: Fitzmaurice, Karen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_25s6h1lgqe8g1nbrrihjbrrscd